ÅǸ޴º
Á¦¸ñ | Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity. Experimental Molecular Medicine 2020 (IF 4.743) | µî·ÏÀÏ | 20200922 | ´Ù¿î·Îµå | |
---|---|---|---|---|---|
Lee WS, Yang H, Chon HJ, Kim C. Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity. Experimental Molecular Medicine 2020 (IF 4.743) (Chttp://www.chamc.co.kr/professor/image/btn_insert.giforresponding author)
|
Copyright ¨Ï chamc, All rights reserved.